Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Improving glucocorticoid therapy for refractory chronic lymphocytic leukemia

EF 2014-15

Résumé
Chronic lymphocytic leukemia is the most common leukemia in the western world, and cannot be cured by chemotherapy. Glucocorticoids, or steroids, are one way to treat patients resistant to chemotherapy, but these patients often develop resistance to steroids as well. We have found that inhibitors of the protein p38 can reverse steroid resistance and kill leukemia cells in test tubes. In addition to producing external signals that cause leukemia cells to grow, p38 may also promote resistance to drugs including steroids. In this project, we will determine which external signals are responsible for steroid resistance in leukemia cells. Once identified, we will use drugs that block these signals to see if they can reverse steroid resistance and kill leukemia cells. This work may result in better treatment options for chemo-resistant leukemia patients that could also work for other cancers.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331595
Name
Lam Avery J
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving glucocorticoid therapy for refractory chronic lymphocytic leukemia
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood; Cancer; Chronic Lymphocytic Leukemia; Cytokines; Glucocorticoids; Leukemias; P38; Resistance; Tumour Microenvironment
Abstract
Chronic lymphocytic leukemia is the most common leukemia in the western world, and cannot be cured by chemotherapy. Glucocorticoids, or steroids, are one way to treat patients resistant to chemotherapy, but these patients often develop resistance to steroids as well. We have found that inhibitors of the protein p38 can reverse steroid resistance and kill leukemia cells in test tubes. In addition to producing external signals that cause leukemia cells to grow, p38 may also promote resistance to drugs including steroids. In this project, we will determine which external signals are responsible for steroid resistance in leukemia cells. Once identified, we will use drugs that block these signals to see if they can reverse steroid resistance and kill leukemia cells. This work may result in better treatment options for chemo-resistant leukemia patients that could also work for other cancers.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lam, Avery J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~